Cas No.: 1926163-30-5
PRODUCT INFORMATION
Description
This tumor-targeted pro-apoptotic peptide, CNGRC-GG-D(KLAKLAK)₂, integrates a tumor-homing CNGRC domain (targeting CD13) and a cytotoxic (KLAKLAK)₂ module. The (KLAKLAK)₂ moiety destabilizes mitochondrial membranes to induce caspase-dependent apoptosis in target cell lines. Its disulfide-bridged architecture enhances accumulation in research models, demonstrating potent in vitro cytotoxic activity.
Molecular Weight
2168.72
Purity
> 95%
Formula
C₉₄H₁₇₄N₃₂O₂₂S₂
Product Type
Targeting Peptide
Sequence
Cys-Asn-Gly-Arg-Cys-Gly-Gly-Lys-Leu-Ala-Lys-Leu-Ala-Lys-Lys-Leu-Ala-Lys-Leu-Ala-Lys-NH₂ (Disulfide bridge:Cys1-Cys5)
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Cyclo(Arg-Gly-Asp-D-Phe-Val) Targeting Peptide (CAT#: OLY-1025-YS-47)
- Thrombospondin-1 (1016-1021) (human, Bovine, Mouse) Targeting Peptide (CAT#: OLY-1025-YS-45)
- LSD Targeting Peptide (CAT#: OLY-1025-YS-2)
- LyP-2 Targeting Peptide (CAT#: OLY-1025-YS-65)
- P160 Targeting Peptide (CAT#: OLY-1025-YS-21)
- Osteocalcin (1-49) (human) Targeting Peptide (CAT#: OLY-1025-YS-9)
- Aminopeptidase N Ligand (CD13) NGR Targeting Peptide (CAT#: OLY-1025-YS-10)
- Cyclo(RGDyK) TFA Targeting Peptide (CAT#: OLY-1025-YS-54)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.